How off-the-shelf gets your NK treatment off-and-running

The clock is ticking for patients awaiting cell therapies. By leveraging our Echo™- NK Manufacturing Platform from end to end, you enable the immediate availability of your natural killer cell therapy in a way that meets the demands of both accelerated timelines and pressured balance sheets.

Artboard 1-1

Ideal Starting Material

Start confidently with Allo Chassis™ immune-cloaked iPSC cell lines derived from primary CD34 cells and ready for immediate use.

 
 
Artboard 7 copy

Product-Specific Gene Edits

Leverage proprietary STAR-CRISPR™ precision editing technology to minimize off-target and unintended modifications.

Cellistic_Picto-05-1

GMP Manufacturing

Differentiate and scale up through our EMA-Certified GMP Facility to guarantee compliance with the highest manufacturing standards.

 
Artboard 1-3

Efficient Platform

Move quickly and smartly with feeder-free, 3D cultures for clinical and commercial production up to 100L.

 

A process built to perform, time and again

Discover how our proven process — honed over 15 years of experience in iPSC-based cell therapies — has been designed and engineered to deliver your program on-target and on-time.    

Click below to discover Cellistic's iPSC-NK manufacturing specifications and download the full process sheet.

Let’s grow your NK program together

If your current NK project could benefit from fast-track development in the hands of a team that’s been working in cell therapy for 15 years, then let’s take the first step together.
Group 38-1

Trusted to turn potential into progress

We work hard on getting all the details right to help it grow where it needs to grow
next. At Cellistic, we’ve invested our resources exclusively into building the expertise and capacity required to help cell therapy leaders capitalize on the full potential of iPSC-focused, platform-based manufacturing. 

Built for Safety
Our process forgoes the need for feeder cells and lympho-depletion, both of which help enhance the odds of favorable immune tolerance.

Built for Speed
Our established Echo Platform – featuring conventional technology, standardized equipment and state-of-the art automation – enables true off-the-shelf efficiency.

Built for Growth
Our process has proven controlled cell expansion with high yields, clearing one of the highest hurdles in cell therapy manufacturing.

Built for Cost-Effectiveness
Our cost structure is transparent, and our approach is designed to help accelerate product development by months if not years.

Peek inside the world’s first facility dedicated exclusively to iPSC-based cell therapy manufacturing

In just over two minutes, our production manager, Pierre-Baptiste Rousseau, walks you through the highlights of our facility in Mont-Saint-Guibert, Belgium. We also hope you’ll take us up on a standing offer to give you a guided tour, so that you can meet the cell therapy manufacturing experts committed to helping your NK project succeed.

Mockup V3

Technical Insights on Echo™-NK from Cellistic

Dive into the unit operations featured in NK cell manufacturing (including components unique to our approach at Cellistic) and explore the critical strategies for scaling NK cell production through characterized cell-expansion techniques.

Learn more about our processes, our platforms, and our people

Everything has to come together just right for your NK program to thrive in manufacturing. Thankfully, it can at Cellistic. Contact us to get a conversation started.

Connect with us

Learn more about our process, our platforms, and our people.

 

Everything has to come together just right for your NK program to thrive in manufacturing. Thankfully, it can at Cellistic. Contact us to get a conversation started.